<?xml version="1.0" encoding="UTF-8"?>
<p id="Par13">Similar to SARS-CoV infection, MERS-CoV infection manifests as a severe lower respiratory tract infection with extrapulmonary involvement and high fatality rates.
 <sup>
  <xref ref-type="bibr" rid="CR19">19</xref>
 </sup> Symptomatic patients may present fever, chills, stiffness, myalgia, discomfort, cough, shortness of breath, and gastrointestinal symptoms of diarrhea, vomiting, and abdominal pain. Pneumonia is common, and severe infection with acute respiratory failure, renal failure, and shock is particularly frequent among older patients.
 <sup>
  <xref ref-type="bibr" rid="CR20">20</xref>
 </sup> Previous studies have estimated that approximately 12.5â€“25% of MERS-CoV infections may be asymptomatic.
 <sup>
  <xref ref-type="bibr" rid="CR20">20</xref>,
  <xref ref-type="bibr" rid="CR38">38</xref>
 </sup> It must be noted that immunocompromised people are at high risk of MERS-CoV infection.
 <sup>
  <xref ref-type="bibr" rid="CR21">21</xref>
 </sup>
</p>
